CHINA MEDICAL SYSTEM HOLDINGS LIMITED (8A8)
General Announcement: NDA of Recombinant Fully Human Bispecific Antibody Against RABV Silevimig Approved in China
General Announcement: NDA of Recombinant Fully Human Bispecific Antibody Against RABV Silevimig Approved in China
Share Buy Back - Daily Share Buy-Back Notice: Share Buy Back - Daily Share Buy Back Notice
General Announcement: Citis 2026 Property and Financials Conference (23 June 2026)
General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT 2016
Share Buy Back - Daily Share Buy-Back Notice: Daily Share Buy-Back Notice
General Announcement: Citis 2026 Property and Financials Conference (23 June 2026)
Change - Announcement of Cessation: Resignation of Chief Operations Officer
Change - Announcement of Appointment: Appointment of Deputy Chief Executive Officer
A meeting convened for June 28, 2026 is postponed to July 21, 2026 – completion of the dialogue process with the advisors of institutional entities among the shareholders
Net Asset Value(s)